Literature DB >> 22395357

Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery?

Andrea Tendas, Luca Cupelli, Antonio Bruno, Pasquale Niscola, Valeria De Angelis, Tiziana Datturi, Flavia Cantoni, Italo De Meis, Teresa Dentamaro, Paolo de Fabritiis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22395357      PMCID： PMC3496232          DOI： 10.2450/2012.0148-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

1.  SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization.

Authors:  M A Gertz; D A Gastineau; M Q Lacy; A Dispenzieri; S R Hayman; S K Kumar; D Dingli; N Leung; R C Wolf; W J Hogan; F K Buadi
Journal:  Bone Marrow Transplant       Date:  2010-10-25       Impact factor: 5.483

2.  Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.

Authors:  Azzurra Romeo; Anna Chierichini; Alessandra Spagnoli; Mariangela Vittori; Michele Vacca; Maria Gozzer; Antonio Spadea; Barbara Anaclerico; Maria Laura Dessanti; Mariella D'Andrea; Giuseppe Toglia; Luciana Annino; Maria Concetta Petti; Andrea Mengarelli; William Arcese
Journal:  Transfusion       Date:  2010-11       Impact factor: 3.157

3.  Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.

Authors:  Robert Rifkin; Gary Spitzer; Gregory Orloff; Romeo Mandanas; Dean McGaughey; Feng Zhan; Kristi A Boehm; Lina Asmar; Roy Beveridge
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-06

4.  Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

Authors:  Sunday Ocheni; Tatjana Zabelina; Ulrike Bacher; Francis Ayuk; Axel Zander; Nicolaus Kröger
Journal:  Leuk Lymphoma       Date:  2009-04

5.  Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.

Authors:  Aaron Gerds; Mary Fox-Geiman; Kevin Dawravoo; Tulio Rodriguez; Amir Toor; Scott Smith; Karen Kiley; Donna Fletcher-Gonzalez; Chindo Hicks; Patrick Stiff
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-04       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.